By The Financial District
Aug 22, 20201 min
A clinical trial for a novel coronavirus vaccine got underway at UC Davis Health in Sacramento on Thursday.
Pfizer picked Sacramento as one of 120 sites to be a part of the worldwide COVID-19 trial. The company aims to enroll about 30,000 participants from across the globe, according to KCRA 3 News.
Both UC Davis Medical Center and Kaiser Permanente are participating in the vaccine trial through a partnership with Pfizer.
UC Davis said it needs more volunteers for the vaccine trial. Participants could earn $700.